Evidence map›Paper›PMID 31504302›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2020

Trends in Hepatitis B Infection and Immunity Among Women of Childbearing Age in the United States.

Tatyana Kushner, Zhen Chen, Stacy Tressler, Harvey Kaufman, Judith Feinberg, Norah A Terrault

Open access · bronzeAbstract read
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023.MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Tatyana KushnerDivision of Liver Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Zhen ChenQuest Diagnostics, Secaucus, New Jersey, USA.
Stacy TresslerDepartment of Epidemiology, School of Public Health, West Virginia University, Morgantown, West Virginia, USA.
Harvey KaufmanQuest Diagnostics, Secaucus, New Jersey, USA.
Judith FeinbergDepartments of Behavioral Medicine & Psychiatry, Neuroscience and Medicine, Division of Infectious Diseases, West Virginia University, Morgantown, USA.
Norah A TerraultDivision of Gastroenterology/Hepatology, University of Southern California, Los Angeles, USA.
Quest Diagnostics (United States) · USWest Virginia University · USIcahn School of Medicine at Mount Sinai · USUniversity of Southern California · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI Sally Lynn Hodder · 2012 to 2026
$81.0M
NIGMS NIH HHS U54 GM104942
6 · The paper itself

Abstract

backgroundThe current opioid injection drug use epidemic has been associated with an increase in hepatitis C virus infections among women of childbearing age in the United States, but changes in hepatitis B virus (HBV) infections have not been studied.

methodsA retrospective analysis of HBV statuses among women of childbearing age nationally and by state was conducted, utilizing the Quest Diagnostics database. Rates of HBV in women born before and after the implementation of universal HBV vaccination recommendations were determined.

resultsWe identified 8 871 965 women tested for HBV from 2011-2017. Nationally, the annual rate of acute HBV infections was stable, but rates increased in Kentucky, Alabama, and Indiana (P < .03). The national prevalence of new, chronic HBV diagnoses decreased significantly, from 0.83% in 2011 to 0.19% in 2017 (P < .0001), but increased in Mississippi, Kentucky, and West Virginia (P ≤ .05). A declining prevalence of HBV seroprotection was evident over time, especially within the birth-dose cohort (which dropped from 48.5% to 38.5%; P < .0001).

conclusionsNational rates of newly diagnosed acute and chronic HBV infections declined or were stable overall, but increased significantly in specific Appalachian states. The HBV vaccine is effective in decreasing infections, but seroprotection wanes over time. These trends in new infections may be related to increased injection drug use and highlight potential gaps in HBV vaccine protection.

Indexed as

Hepatitis BAlabamaFemaleHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B VaccinesHepatitis B virusHumansKentuckyMississippiPrevalenceRetrospective StudiesUnited StatesHepatitis B AntibodiesHepatitis B Surface AntigensHepatitis B Vaccineshepatitis B exposurehepatitis B vaccinationhepatitis B virusreproductive agetesting

Identifiers

PMID31504302
PMCPMC7384310
OpenAlexW2970488594

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.